Liquid Chromatography-Mass Spectrometry LC-MS Analysis and LC-MS/MS: Application of LC/ESI-MS in In Forensic Sciences, Doping Test, Pharmacokinetics, Bioavailability and Bioequivalence study, Environmental, and Agrochemical and Pesticides Industry

Aqeel Faraj Nahi Farhan Al Bolani (1) , Mustafa Abbas Hadi Hamza Al Hashemi (2) , Muntadher Hani Mohsin Abbas Al-Agele (3) , Laith Sajat Abbas Jabbar Al-Tobi (4) , Shaima Misfer Abdel Aziz Jassam Al Ameri (5) , Abbas Ayyed Radhi AL-Dulaimi (6)
(1) Al-Hadi University College, Department of Medical instrumentation Technical Engineering Iraq , Iraq
(2) Al-Hadi University College, Department of Medical instrumentation Technical Engineering Iraq , Iraq
(3) Al-Hadi University College, Department of Medical instrumentation Technical Engineering Iraq , Iraq
(4) Al-Hadi University College, Department of Medical instrumentation Technical Engineering Iraq , Iraq
(5) Al-Hadi University College, Department of Medical instrumentation Technical Engineering Iraq , Iraq
(6) Al-Hadi University College, Department of Medical instrumentation Technical Engineering Iraq , Iraq

Abstract

The technique of LC mass spectrometry is an analytical method that brings together the chromatographic separation of target compounds (or analytes) and the subsequent detection of those compounds based on their mass. In particular, the sensitivity, selectivity, and accuracy of liquid chromatography tandem triple-quadrupole mass spectrometry (LC-MS/MS) have led to the development of procedures that are optimal for detecting nanomolar or even picomolar quantities of a wide variety of analytes. These analytes include drugs, drug and food metabolites, biomarkers of disease progression or drug efficacy, pesticides, food contaminants, markers of ecosystem stability, and natural product extracts. These procedures have been widely utilised because of their unique combination of these characteristics. When it comes to liquid chromatographic separations, the specificity of mass spectrometry detection allows for greater flexibility and efficiency. In the event that quantitative selectivity can be established, the liquid chromatography separation becomes less important for LC/MS/MS than it is for HPLC/UV. This is due to the fact that MS/MS has the ability to detect molecules with differentiable products in a unique manner, even if the molecules co-elute. Simple chromatographic procedures are frequently sufficient for LC/MS/MS, whereas HPLC/UV necessitates complete separation in order to function well. As a consequence of this, the run times that can be achieved using LC/MS/MS can be significantly reduced, and accuracy and precision can be improved. The finest of both worlds is achieved here! Controlling the ionisation process is the most significant obstacle in the identification of multiple sclerosis. When it comes to the MS detector, issues with incomplete ionisation and interference might result in a lack of precision and accuracy. Altering the detection method, utilising a variety of ionisation techniques, utilising sample preparation solvents, utilising LC stationary phases (columns), or LC mobile phases, and utilising chromatographic separations through isocratic or gradient procedures are all potential solutions at your disposal. The time-of-flight MS, the ion capture MS, and other detection methods are also included in the list of other techniques. Electrospray ionisation (ESI), atmospheric pressure chemical ionisation (APCI), photoionization, and other specialised techniques are all examples of methodological approaches that fall under the category of source ionisation. The precision, accuracy, selectivity, and sensitivity of MS detection are all improved by the use of these one-of-a-kind approaches, which make use of various MS detector setups. Additionally, because it is necessary to minimise the introduction of non-volatile components to the MS source, the choices of LC buffer salts are restricted to volatile buffer systems (typically ammonium cations with formate or acetate anions). These buffer systems may offer limited buffering capacity at typical mobile phase pH levels.

Full text article

Generated from XML file

References

Dolan JW, Snyder LR. (1989) Injectors and autosamplers. In: Troubleshooting LC Systems. Humana Press, Totowa, NJ. doi:10.1007/978-1-59259-640-9_10

Medhe S. Mass spectrometry: Detectors review. Chem. Biomol. Eng. (2018); 3(4):51–58. doi:10.11648/j.cbe.20180304.11

Markgraf DF, Al-Hasani H, Lehr S. Lipidomics—Reshaping the analysis and perception of Type 2 diabetes. Int. J. Mol. Sci. 2016;17(11):1841. doi: 10.3390/ijms17111841

Chidella K, Dasari VB, and Anireddy J. Simultaneous and trace level quantification of five potential genotoxic impurities in ranolazine active pharmaceutical ingredient using LC-MS/MS. Am. J. Analyt. Chem, 2021;12:1–14.

Thevis M, Krug O, Geyer H, Schänzer W. Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath. Rapid Commun. Mass Spectrom. 2017;31(15):1290–1296.

Frank N, Bessaire T, Tarres A, Goyon A, Thierry Delatour. Development of a quantitative multi-compound method for the detection of 14 nitrogen-rich adulterants by LC-MS/MS in food materials, Food Addit. Contam: Part A. 2017;34(11):1842–1852.

Dincel D, Olgan H, Canbaloğlu Z et al. Determination of dihydrocapsaicin adulteration in dietary supplements using LC-MS/MS. J. Chem. Metrol. 2020; 14(1):77–82. doi: 10.25135/jcm.36.20.01.1532

Mahalakshmi R, Pugazhendhi A, Brindhadevi K, Ramesh N. Analysis of Alkylphenol ethoxylates (APEOs) from tannery sediments using LC–MS and their environmental risks. Process Biochem. 2020;97:37–42, ISSN 1359–5113, doi: 10.1016/j.procbio.2020.06.015

Kharbouche L, Gil García MD, Lozano A, Hamaizi H, Martínez Galera M. Determination of personal care products in water using UHPLC–MS after solid phase extraction with mesoporous silica‐based MCM‐41 functionalized with cyanopropyl groups. J. Sep. Sci. 2020;43:2142–2153. doi: 10.1002/jssc.201901148

Zborníková E, Knejzlík Z, Hauryliuk V, Krásný L, Rejman D. Analysis of nucleotide pools in bacteria using HPLC-MS in HILIC mode. Talanta. 2019; 205.120161. doi: 10.1016/j.talanta.2019.120161

Xiao, J. F.; Zhou, B.; Ressom, H. W., Metabolite identification and quantitation in LC-MS/MS-based metabolomics. TrAC Trends in Analytical Chemistry 2012, 32, 1-14.

Tarning, J.; Bergqvist, Y.; Day, N.P.; Bergquist, J.; Arvidsson, B.; White, N. J., Characterization of human urinary metabolites of the antimalarial piperaquine. Drug Metab. Dispos. 2006, 34 (12), 2011–2019.

Aziz, M. Y.; Hoffmann, K.-J.; Ashton, M., LC–MS/MS quantitation of antimalarial drug piperaquine and metabolites in human plasma. Journal of Chromatography B 2017, 1063, 253-258.

Jansen, R.S.; Rosing, H.; Schellens, J.H.; Beijnen, J.H. Mass spectrometry in the quantitative analysis of therapeutic intracellular nucleotide analogs. Mass Spectrom. Rev. 2011, 30 (2) 321–343.

Gautam, N.; Lin, Z.; Banoub, M. G.; Smith, N. A.; Maayah, A. Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC–MS/MS Journal of Pharmaceutical and Biomedical Analysis 2018, 153, 248-259.

Schuster O, Zvi A, Rosen O, et al. Specific and rapid SARS-CoV-2 identification based on LC-MS/MS analysis. ACS Omega 2021;6 (5):3525–3534.

Pavia DL, Lampman GM, Kriz GS, Vyvyan JR Introduction to Spectroscopy, 5th (edn), pp.120-122.

Steel C, Michael Henchman (1998) Understanding the Quadrupole Mass Filter through Computer Simulation. J Chem Educ 75(8): 1049-1054.

Guilhaus M (1995) Special Feature: Tutorial, Principles and Instrumentation in Time-of-flight Mass Spectrometry, Physical and Instrumental Concepts. Journal Of Mass Spectrometry 30(11): 1519- 1532.

Raymond EM, John FT (1995) Practical Aspects of Ion Trap Mass Spectrometry Volume-III, Chemical, Environmental and Biomedical Applications. By CRC Press, USA, Inc p. 4-19.

Raymond EM, John FJ Todd (1995) Special Feature: Tutorial an Introduction to Quadrupole Ion Trap Mass Spectrometry. Journal Of Mass Spectrometry 32: 351-369.

Barnes IVJH, Hieftje GM (2004) Review Recent advances in detectorarray technology for mass spectrometry. International Journal of Mass Spectrometry 238(1): 33-46.

Kang JS (2012) Principles and Applications of LC-MS/Ms for the Quantitative Bioanalysis of Analytes in Various Biological Samples 441- 492.

Settle FA (2004) Handbook of Instrumental techniques for Analytical Chemistry. First Indian Reprint 569-660.

Perrenoud L, Saugy M, Saudan C (2009) Short communication Detection in urine of 4-methyl-2-hexaneamine, a doping agent. Journal of Chromatography 877(9): 3767-3770.

Sargel L, Wu-Pongs, Yu ABC (2005) Applied Biopharmaceutics and Pharmacokinetics. 5th (edn) Mc Graw-Hill, New York, USA, p. 5-9.

Authors

Aqeel Faraj Nahi Farhan Al Bolani
Mustafa Abbas Hadi Hamza Al Hashemi
Muntadher Hani Mohsin Abbas Al-Agele
Laith Sajat Abbas Jabbar Al-Tobi
Shaima Misfer Abdel Aziz Jassam Al Ameri
Abbas Ayyed Radhi AL-Dulaimi
Al Bolani, A. F. N. F., Hashemi, M. A. H. H. A., Al-Agele, M. H. M. A., Al-Tobi, L. S. A. J., Al Ameri, S. M. A. A. J., & AL-Dulaimi, A. A. R. (2024). Liquid Chromatography-Mass Spectrometry LC-MS Analysis and LC-MS/MS: Application of LC/ESI-MS in In Forensic Sciences, Doping Test, Pharmacokinetics, Bioavailability and Bioequivalence study, Environmental, and Agrochemical and Pesticides Industry. Journal of Current Medical Research and Opinion, 7(07), 3201–3216. https://doi.org/10.52845/CMRO/2024/7-7-15

Article Details